In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
December 3rd, 2008 | 28 | Yes |
Popular Name: Flavopiridol Flavopiridol
Find On: PubMed — Wikipedia — Google
CAS Numbers: 131740-09-5 , 146426-40-6
(-)cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one
131740-09-5; Alvocidib hydrochloride (USAN); D02880
146426-40-6; Alvocidib (USAN/INN); D09868
2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE
2-(2-Chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one
2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one
HL-275; HMR-1275; L-86-8275; MDL-107826A; NSC-649890
HL-275; HMR-1275; L-868275; L-86-8275; MDL-107826A; NSC-649890
HL-275; HMR-1275; L86-8275; MDL-107826A; NSC-649890; L-86-8275
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.46 | 7.04 | -50.59 | 4 | 6 | 1 | 95 | 402.854 | 2 | ↓ |
Hi High (pH 8-9.5) | 3.46 | 7.74 | -91.2 | 3 | 6 | 0 | 98 | 401.846 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.40e-02 g/l | DrugBank-experimental |
Target | CDK | Selleck Chemicals |
PUBCHEM_PATENT_ID | EP0150999A2; EP0150999B1; EP0167248A2; EP0167248B1; EP0170446A1; EP0170446B1; EP0222279A2; EP0244932A2; EP0257052A1; EP0338439A1; EP0338440A1; EP0343696A2; EP0395124A1; EP0874847A1; EP0888458A1; EP0912535A1; EP0914116A1; EP0914116B1; EP0919244A2; EP095538 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
AAK1-1-E | Adaptor-associated Kinase (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5300 | 0.26 | Binding ≤ 10μM |
AAPK1-1-E | AMP-activated Protein Kinase, Alpha-1 Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6600 | 0.26 | Binding ≤ 10μM |
ACVR1-1-E | Activin Receptor Type-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1900 | 0.29 | Binding ≤ 10μM |
ALK-1-E | ALK Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 670 | 0.31 | Binding ≤ 10μM |
AVR2B-1-E | Activin Receptor Type-2B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2400 | 0.28 | Binding ≤ 10μM |
CCNA1-1-E | Cyclin A1 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 70 | 0.36 | Binding ≤ 10μM |
CCNA2-1-E | Cyclin A2 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 70 | 0.36 | Binding ≤ 10μM |
CCNB-1-E | G2/mitotic-specific Cyclin B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.32 | Binding ≤ 10μM |
CCNB1-1-E | G2/mitotic-specific Cyclin B1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
CCNB2-1-E | G2/mitotic-specific Cyclin B2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
CCNB3-1-E | G2/mitotic-specific Cyclin B3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
CCND1-1-E | G1/S-specific Cyclin D1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
CCND2-1-E | G1/S-specific Cyclin D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
CCND3-1-E | G1/S-specific Cyclin D3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
CCNE1-1-E | G1/S-specific Cyclin E1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
CCNE2-1-E | G1/S-specific Cyclin E2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
CCNH-1-E | Cyclin H (cluster #1 Of 1), Eukaryotic | Eukaryotes | 400 | 0.32 | Binding ≤ 10μM |
CDK1-1-E | Cyclin-dependent Kinase 1 (cluster #1 Of 4), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
CDK14-1-E | Serine/threonine-protein Kinase PFTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.35 | Binding ≤ 10μM |
CDK16-1-E | Serine/threonine-protein Kinase PCTAIRE-1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 440 | 0.32 | Binding ≤ 10μM |
CDK17-1-E | Serine/threonine-protein Kinase PCTAIRE-2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 480 | 0.32 | Binding ≤ 10μM |
CDK18-1-E | Serine/threonine-protein Kinase PCTAIRE-3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
CDK19-1-E | Cell Division Cycle 2-like Protein Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 57 | 0.36 | Binding ≤ 10μM |
CDK2-1-E | Cyclin-dependent Kinase 2 (cluster #1 Of 5), Eukaryotic | Eukaryotes | 960 | 0.30 | Binding ≤ 10μM |
CDK3-1-E | Cyclin-dependent Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 410 | 0.32 | Binding ≤ 10μM |
CDK4-2-E | Cyclin-dependent Kinase 4 (cluster #2 Of 3), Eukaryotic | Eukaryotes | 100 | 0.35 | Binding ≤ 10μM |
CDK5-1-E | Cyclin-dependent Kinase 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 43 | 0.37 | Binding ≤ 10μM |
CDK6-1-E | Cyclin-dependent Kinase 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 80 | 0.35 | Binding ≤ 10μM |
CDK7-1-E | Cyclin-dependent Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 875 | 0.30 | Binding ≤ 10μM |
CDK8-1-E | Cell Division Protein Kinase 8 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 120 | 0.35 | Binding ≤ 10μM |
CDK9-1-E | Cyclin-dependent Kinase 9 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 6 | 0.41 | Binding ≤ 10μM |
CLK1-1-E | Dual Specificty Protein Kinase CLK1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
CLK2-1-E | Dual Specificity Protein Kinase CLK2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
CLK3-1-E | Dual Specificity Protein Kinase CLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
CSF1R-1-E | Macrophage Colony-stimulating Factor 1 Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
CTRO-1-E | Citron Rho-interacting Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 110 | 0.35 | Binding ≤ 10μM |
DCLK1-1-E | Serine/threonine-protein Kinase DCLK1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2100 | 0.28 | Binding ≤ 10μM |
DCLK3-1-E | Serine/threonine-protein Kinase DCLK3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
DMPK-1-E | Myotonin-protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 650 | 0.31 | Binding ≤ 10μM |
DYR1B-1-E | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 84 | 0.35 | Binding ≤ 10μM |
E2AK2-1-E | Interferon-induced, Double-stranded RNA-activated Protein Kinase (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
EGFR-2-E | Epidermal Growth Factor Receptor ErbB1 (cluster #2 Of 4), Eukaryotic | Eukaryotes | 7600 | 0.26 | Binding ≤ 10μM |
EPHA2-1-E | Ephrin Type-A Receptor 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2500 | 0.28 | Binding ≤ 10μM |
EPHA3-1-E | Ephrin Type-A Receptor 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
EPHA5-1-E | Ephrin Type-A Receptor 5 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4000 | 0.27 | Binding ≤ 10μM |
EPHB1-1-E | Ephrin Type-B Receptor 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
FLT3-1-E | Tyrosine-protein Kinase Receptor FLT3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6500 | 0.26 | Binding ≤ 10μM |
GAK-1-E | Serine/threonine-protein Kinase GAK (cluster #1 Of 2), Eukaryotic | Eukaryotes | 370 | 0.32 | Binding ≤ 10μM |
GSK3A-1-E | Glycogen Synthase Kinase-3 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
GSK3B-7-E | Glycogen Synthase Kinase-3 Beta (cluster #7 Of 7), Eukaryotic | Eukaryotes | 730 | 0.31 | Binding ≤ 10μM |
IKKE-1-E | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
KCC2A-1-E | CaM Kinase II Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
KCC2B-1-E | CaM Kinase II Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2600 | 0.28 | Binding ≤ 10μM |
KCC4-1-E | CaM Kinase IV (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3200 | 0.27 | Binding ≤ 10μM |
KIT-1-E | Stem Cell Growth Factor Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4600 | 0.27 | Binding ≤ 10μM |
KKCC1-1-E | CaM-kinase Kinase Alpha (cluster #1 Of 1), Eukaryotic | Eukaryotes | 79 | 0.36 | Binding ≤ 10μM |
KKCC2-1-E | CaM-kinase Kinase Beta (cluster #1 Of 2), Eukaryotic | Eukaryotes | 430 | 0.32 | Binding ≤ 10μM |
KPCA-1-E | Protein Kinase C Alpha (cluster #1 Of 6), Eukaryotic | Eukaryotes | 2800 | 0.28 | Binding ≤ 10μM |
KPCB-1-E | Protein Kinase C Beta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
KPCD-1-E | Protein Kinase C Delta (cluster #1 Of 4), Eukaryotic | Eukaryotes | 890 | 0.30 | Binding ≤ 10μM |
KPCD1-1-E | Protein Kinase C Mu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 520 | 0.31 | Binding ≤ 10μM |
KPCD2-1-E | Serine/threonine-protein Kinase D2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1100 | 0.30 | Binding ≤ 10μM |
KPCD3-1-E | Protein Kinase C Nu (cluster #1 Of 3), Eukaryotic | Eukaryotes | 170 | 0.34 | Binding ≤ 10μM |
KPCE-1-E | Protein Kinase C Epsilon (cluster #1 Of 5), Eukaryotic | Eukaryotes | 480 | 0.32 | Binding ≤ 10μM |
KPCG-1-E | Protein Kinase C Gamma (cluster #1 Of 4), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
KPCI-1-E | Protein Kinase C Iota (cluster #1 Of 3), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
KPCL-2-E | Protein Kinase C Eta (cluster #2 Of 4), Eukaryotic | Eukaryotes | 350 | 0.32 | Binding ≤ 10μM |
KPCT-1-E | Protein Kinase C Theta (cluster #1 Of 3), Eukaryotic | Eukaryotes | 350 | 0.32 | Binding ≤ 10μM |
KPCZ-1-E | Protein Kinase C Zeta (cluster #1 Of 5), Eukaryotic | Eukaryotes | 10000 | 0.25 | Binding ≤ 10μM |
KS6A1-1-E | Ribosomal Protein S6 Kinase Alpha 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 720 | 0.31 | Binding ≤ 10μM |
KS6A2-1-E | Ribosomal Protein S6 Kinase Alpha 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.29 | Binding ≤ 10μM |
KS6A4-1-E | Ribosomal Protein S6 Kinase Alpha 4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1300 | 0.29 | Binding ≤ 10μM |
KS6A5-1-E | Ribosomal Protein S6 Kinase Alpha 5 (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2000 | 0.28 | Binding ≤ 10μM |
KS6A6-1-E | Ribosomal Protein S6 Kinase Alpha 6 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 800 | 0.30 | Binding ≤ 10μM |
LTK-1-E | Leukocyte Tyrosine Kinase Receptor (cluster #1 Of 1), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
M3K10-1-E | Mitogen-activated Protein Kinase Kinase Kinase 10 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5200 | 0.26 | Binding ≤ 10μM |
M3K9-1-E | Mitogen-activated Protein Kinase Kinase Kinase 9 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5700 | 0.26 | Binding ≤ 10μM |
M4K1-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
M4K3-1-E | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 4500 | 0.27 | Binding ≤ 10μM |
MERTK-1-E | Proto-oncogene Tyrosine-protein Kinase MER (cluster #1 Of 1), Eukaryotic | Eukaryotes | 6800 | 0.26 | Binding ≤ 10μM |
MK07-1-E | Mitogen-activated Protein Kinase 7 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 620 | 0.31 | Binding ≤ 10μM |
MK10-1-E | C-Jun N-terminal Kinase 3 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5500 | 0.26 | Binding ≤ 10μM |
MK15-1-E | Mitogen-activated Protein Kinase 15 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 330 | 0.32 | Binding ≤ 10μM |
MKNK2-1-E | MAP Kinase Signal-integrating Kinase 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 3200 | 0.27 | Binding ≤ 10μM |
MRCKA-1-E | Serine/threonine-protein Kinase MRCK-A (cluster #1 Of 1), Eukaryotic | Eukaryotes | 9500 | 0.25 | Binding ≤ 10μM |
MRCKB-1-E | Serine/threonine-protein Kinase MRCK Beta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3300 | 0.27 | Binding ≤ 10μM |
NUAK2-1-E | NUAK Family SNF1-like Kinase 2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
PHKG1-1-E | Phosphorylase Kinase Gamma Subunit 1 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2200 | 0.28 | Binding ≤ 10μM |
PHKG2-1-E | Phosphorylase Kinase Gamma Subunit 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 2900 | 0.28 | Binding ≤ 10μM |
PIM1-1-E | Serine/threonine-protein Kinase PIM1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 560 | 0.31 | Binding ≤ 10μM |
PIM2-1-E | Serine/threonine-protein Kinase PIM2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 770 | 0.31 | Binding ≤ 10μM |
PIM3-1-E | Serine/threonine-protein Kinase PIM3 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 600 | 0.31 | Binding ≤ 10μM |
PKN1-1-E | Protein Kinase N1 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.27 | Binding ≤ 10μM |
PLK4-1-E | Serine/threonine-protein Kinase PLK4 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3100 | 0.28 | Binding ≤ 10μM |
PYGM-2-E | Muscle Glycogen Phosphorylase (cluster #2 Of 4), Eukaryotic | Eukaryotes | 1000 | 0.30 | Binding ≤ 10μM |
SRMS-1-E | Tyrosine-protein Kinase Srms (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1400 | 0.29 | Binding ≤ 10μM |
ST17B-1-E | Serine/threonine-protein Kinase 17B (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5100 | 0.26 | Binding ≤ 10μM |
STK3-1-E | Serine/threonine-protein Kinase MST2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 9400 | 0.25 | Binding ≤ 10μM |
STK33-1-E | Serine/threonine-protein Kinase 33 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 1700 | 0.29 | Binding ≤ 10μM |
TGFR2-1-E | TGF-beta Receptor Type II (cluster #1 Of 1), Eukaryotic | Eukaryotes | 5600 | 0.26 | Binding ≤ 10μM |
TNI3K-1-E | Serine/threonine-protein Kinase TNNI3K (cluster #1 Of 1), Eukaryotic | Eukaryotes | 55 | 0.36 | Binding ≤ 10μM |
UFO-1-E | Tyrosine-protein Kinase Receptor UFO (cluster #1 Of 1), Eukaryotic | Eukaryotes | 3500 | 0.27 | Binding ≤ 10μM |
Z104294-2-O | Cyclin-dependent Kinase 5/CDK5 Activator 1 (cluster #2 Of 2), Other | Other | 170 | 0.34 | Binding ≤ 10μM |
Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 90 | 0.35 | Binding ≤ 10μM |
Z104295-1-O | Cyclin-dependent Kinase 4/cyclin D1 (cluster #1 Of 2), Other | Other | 100 | 0.35 | Binding ≤ 10μM |
Z104296-1-O | Cyclin-dependent Kinase 1/cyclin B1 (cluster #1 Of 2), Other | Other | 30 | 0.38 | Binding ≤ 10μM |
Z100090-1-O | ABAE (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 45 | 0.37 | Functional ≤ 10μM |
Z100091-1-O | HS27 (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 51 | 0.36 | Functional ≤ 10μM |
Z100093-1-O | LX-1 (Lung Carcinoma Cells) (cluster #1 Of 1), Other | Other | 75 | 0.36 | Functional ≤ 10μM |
Z100094-1-O | MLF (Lung Fibroblast Cells) (cluster #1 Of 1), Other | Other | 72 | 0.36 | Functional ≤ 10μM |
Z100095-1-O | MIP (Colon Carcinoma Cells) (cluster #1 Of 1), Other | Other | 120 | 0.35 | Functional ≤ 10μM |
Z80054-1-O | Caco-2 (Colon Adenocarcinoma Cells) (cluster #1 Of 4), Other | Other | 86 | 0.35 | Functional ≤ 10μM |
Z80064-1-O | CCRF-CEM (T-cell Leukemia) (cluster #1 Of 9), Other | Other | 52 | 0.36 | Functional ≤ 10μM |
Z80156-2-O | HL-60 (Promyeloblast Leukemia Cells) (cluster #2 Of 12), Other | Other | 46 | 0.37 | Functional ≤ 10μM |
Z80186-9-O | K562 (Erythroleukemia Cells) (cluster #9 Of 11), Other | Other | 130 | 0.34 | Functional ≤ 10μM |
Z80224-1-O | MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other | Other | 66 | 0.36 | Functional ≤ 10μM |
Z80354-4-O | OVCAR-3 (Ovarian Adenocarcinoma Cells) (cluster #4 Of 4), Other | Other | 54 | 0.36 | Functional ≤ 10μM |
Z80390-1-O | PC-3 (Prostate Carcinoma Cells) (cluster #1 Of 10), Other | Other | 66 | 0.36 | Functional ≤ 10μM |
Z80475-1-O | SK-BR-3 (Breast Adenocarcinoma) (cluster #1 Of 3), Other | Other | 77 | 0.36 | Functional ≤ 10μM |
Z80675-1-O | AG1523 (Fibroblast Cells) (cluster #1 Of 1), Other | Other | 6700 | 0.26 | Functional ≤ 10μM |
Z80682-1-O | A549 (Lung Carcinoma Cells) (cluster #1 Of 11), Other | Other | 96 | 0.35 | Functional ≤ 10μM |
Z80852-2-O | A-431 (Epidermoid Carcinoma Cells) (cluster #2 Of 3), Other | Other | 75 | 0.36 | Functional ≤ 10μM |
Z80928-1-O | HCT-116 (Colon Carcinoma Cells) (cluster #1 Of 9), Other | Other | 490 | 0.32 | Functional ≤ 10μM |
Z81034-1-O | A2780 (Ovarian Carcinoma Cells) (cluster #1 Of 10), Other | Other | 78 | 0.36 | Functional ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 16 | 0.39 | Functional ≤ 10μM |
Z81186-1-O | LS174T (Colon Adencocarcinoma Cells) (cluster #1 Of 2), Other | Other | 65 | 0.36 | Functional ≤ 10μM |
Z81225-1-O | M109 (Lung Carcinoma Cells) (cluster #1 Of 2), Other | Other | 80 | 0.35 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 670 | 0.31 | Binding ≤ 1μM |
KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 19 | 0.39 | Binding ≤ 1μM |
KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 320 | 0.32 | Binding ≤ 1μM |
CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 57 | 0.36 | Binding ≤ 1μM |
CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 120 | 0.35 | Binding ≤ 1μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 110 | 0.35 | Binding ≤ 1μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 50 | 0.37 | Binding ≤ 1μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 50 | 0.37 | Binding ≤ 1μM |
CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.32 | Binding ≤ 1μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 210 | 0.33 | Binding ≤ 1μM |
Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 200 | 0.33 | Binding ≤ 1μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 170 | 0.34 | Binding ≤ 1μM |
CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 410 | 0.32 | Binding ≤ 1μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 100 | 0.35 | Binding ≤ 1μM |
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 100 | 0.35 | Binding ≤ 1μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 110 | 0.35 | Binding ≤ 1μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 170 | 0.34 | Binding ≤ 1μM |
CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 80 | 0.35 | Binding ≤ 1μM |
CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 23 | 0.38 | Binding ≤ 1μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 20 | 0.38 | Binding ≤ 1μM |
CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 1000 | 0.30 | Binding ≤ 1μM |
DYR1B_HUMAN | Q9Y463 | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B, Human | 84 | 0.35 | Binding ≤ 1μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 100 | 0.35 | Binding ≤ 1μM |
CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 100 | 0.35 | Binding ≤ 1μM |
CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 100 | 0.35 | Binding ≤ 1μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 170 | 0.34 | Binding ≤ 1μM |
CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 170 | 0.34 | Binding ≤ 1μM |
CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 400 | 0.32 | Binding ≤ 1μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 210 | 0.33 | Binding ≤ 1μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 210 | 0.33 | Binding ≤ 1μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 210 | 0.33 | Binding ≤ 1μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 280 | 0.33 | Binding ≤ 1μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 280 | 0.33 | Binding ≤ 1μM |
MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 330 | 0.32 | Binding ≤ 1μM |
MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 620 | 0.31 | Binding ≤ 1μM |
PYGM_HUMAN | P11217 | Muscle Glycogen Phosphorylase, Human | 1000 | 0.30 | Binding ≤ 1μM |
DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 650 | 0.31 | Binding ≤ 1μM |
KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 590 | 0.31 | Binding ≤ 1μM |
KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 380 | 0.32 | Binding ≤ 1μM |
KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 350 | 0.32 | Binding ≤ 1μM |
KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 520 | 0.31 | Binding ≤ 1μM |
KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 170 | 0.34 | Binding ≤ 1μM |
KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 350 | 0.32 | Binding ≤ 1μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 720 | 0.31 | Binding ≤ 1μM |
KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 800 | 0.30 | Binding ≤ 1μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 370 | 0.32 | Binding ≤ 1μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.34 | Binding ≤ 1μM |
CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 480 | 0.32 | Binding ≤ 1μM |
CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 110 | 0.35 | Binding ≤ 1μM |
PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 520 | 0.31 | Binding ≤ 1μM |
PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 650 | 0.31 | Binding ≤ 1μM |
PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 600 | 0.31 | Binding ≤ 1μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 55 | 0.36 | Binding ≤ 1μM |
ACVR1_HUMAN | Q04771 | Activin Receptor Type-1, Human | 1900 | 0.29 | Binding ≤ 10μM |
AVR2B_HUMAN | Q13705 | Activin Receptor Type-2B, Human | 2400 | 0.28 | Binding ≤ 10μM |
AAK1_HUMAN | Q2M2I8 | Adaptor-associated Kinase, Human | 5300 | 0.26 | Binding ≤ 10μM |
ALK_HUMAN | Q9UM73 | ALK Tyrosine Kinase Receptor, Human | 670 | 0.31 | Binding ≤ 10μM |
AAPK1_HUMAN | Q13131 | AMP-activated Protein Kinase, Alpha-1 Subunit, Human | 6600 | 0.26 | Binding ≤ 10μM |
MK10_HUMAN | P53779 | C-Jun N-terminal Kinase 3, Human | 5500 | 0.26 | Binding ≤ 10μM |
KCC2A_HUMAN | Q9UQM7 | CaM Kinase II Alpha, Human | 1300 | 0.29 | Binding ≤ 10μM |
KCC2B_HUMAN | Q13554 | CaM Kinase II Beta, Human | 2600 | 0.28 | Binding ≤ 10μM |
KCC4_HUMAN | Q16566 | CaM Kinase IV, Human | 3200 | 0.27 | Binding ≤ 10μM |
KKCC1_HUMAN | Q8N5S9 | CaM-kinase Kinase Alpha, Human | 19 | 0.39 | Binding ≤ 10μM |
KKCC2_HUMAN | Q96RR4 | CaM-kinase Kinase Beta, Human | 320 | 0.32 | Binding ≤ 10μM |
CDK19_HUMAN | Q9BWU1 | Cell Division Cycle 2-like Protein Kinase 6, Human | 57 | 0.36 | Binding ≤ 10μM |
CDK8_HUMAN | P49336 | Cell Division Protein Kinase 8, Human | 120 | 0.35 | Binding ≤ 10μM |
CTRO_HUMAN | O14578 | Citron Rho-interacting Kinase, Human | 110 | 0.35 | Binding ≤ 10μM |
CCNA1_HUMAN | P78396 | Cyclin A1, Human | 1500 | 0.29 | Binding ≤ 10μM |
CCNA2_HUMAN | P20248 | Cyclin A2, Human | 1500 | 0.29 | Binding ≤ 10μM |
CCNH_HUMAN | P51946 | Cyclin H, Human | 400 | 0.32 | Binding ≤ 10μM |
CDK1_HUMAN | P06493 | Cyclin-dependent Kinase 1, Human | 210 | 0.33 | Binding ≤ 10μM |
Z104296 | Z104296 | Cyclin-dependent Kinase 1/cyclin B1 | 200 | 0.33 | Binding ≤ 10μM |
CDK2_HUMAN | P24941 | Cyclin-dependent Kinase 2, Human | 1500 | 0.29 | Binding ≤ 10μM |
CDK3_HUMAN | Q00526 | Cyclin-dependent Kinase 3, Human | 410 | 0.32 | Binding ≤ 10μM |
CDK4_HUMAN | P11802 | Cyclin-dependent Kinase 4, Human | 100 | 0.35 | Binding ≤ 10μM |
Z104295 | Z104295 | Cyclin-dependent Kinase 4/cyclin D1 | 100 | 0.35 | Binding ≤ 10μM |
CDK5_HUMAN | Q00535 | Cyclin-dependent Kinase 5, Human | 110 | 0.35 | Binding ≤ 10μM |
Z104294 | Z104294 | Cyclin-dependent Kinase 5/CDK5 Activator 1 | 170 | 0.34 | Binding ≤ 10μM |
CDK6_HUMAN | Q00534 | Cyclin-dependent Kinase 6, Human | 80 | 0.35 | Binding ≤ 10μM |
CDK7_HUMAN | P50613 | Cyclin-dependent Kinase 7, Human | 23 | 0.38 | Binding ≤ 10μM |
CDK9_HUMAN | P50750 | Cyclin-dependent Kinase 9, Human | 20 | 0.38 | Binding ≤ 10μM |
CLK2_HUMAN | P49760 | Dual Specificity Protein Kinase CLK2, Human | 1400 | 0.29 | Binding ≤ 10μM |
CLK3_HUMAN | P49761 | Dual Specificity Protein Kinase CLK3, Human | 1000 | 0.30 | Binding ≤ 10μM |
DYR1B_HUMAN | Q9Y463 | Dual Specificity Tyrosine-phosphorylation-regulated Kinase 1B, Human | 84 | 0.35 | Binding ≤ 10μM |
CLK1_HUMAN | P49759 | Dual Specificty Protein Kinase CLK1, Human | 1700 | 0.29 | Binding ≤ 10μM |
EPHA2_HUMAN | P29317 | Ephrin Type-A Receptor 2, Human | 2500 | 0.28 | Binding ≤ 10μM |
EPHA3_HUMAN | P29320 | Ephrin Type-A Receptor 3, Human | 3300 | 0.27 | Binding ≤ 10μM |
EPHA5_HUMAN | P54756 | Ephrin Type-A Receptor 5, Human | 4000 | 0.27 | Binding ≤ 10μM |
EPHB1_HUMAN | P54762 | Ephrin Type-B Receptor 1, Human | 2200 | 0.28 | Binding ≤ 10μM |
EGFR_HUMAN | P00533 | Epidermal Growth Factor Receptor ErbB1, Human | 1400 | 0.29 | Binding ≤ 10μM |
CCND1_HUMAN | P24385 | G1/S-specific Cyclin D1, Human | 100 | 0.35 | Binding ≤ 10μM |
CCND2_HUMAN | P30279 | G1/S-specific Cyclin D2, Human | 100 | 0.35 | Binding ≤ 10μM |
CCND3_HUMAN | P30281 | G1/S-specific Cyclin D3, Human | 100 | 0.35 | Binding ≤ 10μM |
CCNE1_HUMAN | P24864 | G1/S-specific Cyclin E1, Human | 170 | 0.34 | Binding ≤ 10μM |
CCNE2_HUMAN | O96020 | G1/S-specific Cyclin E2, Human | 170 | 0.34 | Binding ≤ 10μM |
CCNB_MARGL | P15206 | G2/mitotic-specific Cyclin B, Margl | 400 | 0.32 | Binding ≤ 10μM |
CCNB1_HUMAN | P14635 | G2/mitotic-specific Cyclin B1, Human | 210 | 0.33 | Binding ≤ 10μM |
CCNB2_HUMAN | O95067 | G2/mitotic-specific Cyclin B2, Human | 210 | 0.33 | Binding ≤ 10μM |
CCNB3_HUMAN | Q8WWL7 | G2/mitotic-specific Cyclin B3, Human | 210 | 0.33 | Binding ≤ 10μM |
GSK3A_HUMAN | P49840 | Glycogen Synthase Kinase-3 Alpha, Human | 280 | 0.33 | Binding ≤ 10μM |
GSK3B_HUMAN | P49841 | Glycogen Synthase Kinase-3 Beta, Human | 280 | 0.33 | Binding ≤ 10μM |
IKKE_HUMAN | Q14164 | Inhibitor Of Nuclear Factor Kappa B Kinase Epsilon Subunit, Human | 3100 | 0.28 | Binding ≤ 10μM |
E2AK2_HUMAN | P19525 | Interferon-induced, Double-stranded RNA-activated Protein Kinase, Human | 5200 | 0.26 | Binding ≤ 10μM |
LTK_HUMAN | P29376 | Leukocyte Tyrosine Kinase Receptor, Human | 2200 | 0.28 | Binding ≤ 10μM |
CSF1R_HUMAN | P07333 | Macrophage Colony Stimulating Factor Receptor, Human | 2800 | 0.28 | Binding ≤ 10μM |
MKNK2_HUMAN | Q9HBH9 | MAP Kinase Signal-integrating Kinase 2, Human | 1900 | 0.29 | Binding ≤ 10μM |
MK15_HUMAN | Q8TD08 | Mitogen-activated Protein Kinase 15, Human | 330 | 0.32 | Binding ≤ 10μM |
MK07_HUMAN | Q13164 | Mitogen-activated Protein Kinase 7, Human | 620 | 0.31 | Binding ≤ 10μM |
M3K10_HUMAN | Q02779 | Mitogen-activated Protein Kinase Kinase Kinase 10, Human | 5200 | 0.26 | Binding ≤ 10μM |
M3K9_HUMAN | P80192 | Mitogen-activated Protein Kinase Kinase Kinase 9, Human | 5700 | 0.26 | Binding ≤ 10μM |
M4K1_HUMAN | Q92918 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 1, Human | 3300 | 0.27 | Binding ≤ 10μM |
M4K3_HUMAN | Q8IVH8 | Mitogen-activated Protein Kinase Kinase Kinase Kinase 3, Human | 4500 | 0.27 | Binding ≤ 10μM |
PYGM_HUMAN | P11217 | Muscle Glycogen Phosphorylase, Human | 1000 | 0.30 | Binding ≤ 10μM |
DMPK_HUMAN | Q09013 | Myotonin-protein Kinase, Human | 650 | 0.31 | Binding ≤ 10μM |
NUAK2_HUMAN | Q9H093 | NUAK Family SNF1-like Kinase 2, Human | 1400 | 0.29 | Binding ≤ 10μM |
PHKG1_HUMAN | Q16816 | Phosphorylase Kinase Gamma Subunit 1, Human | 2200 | 0.28 | Binding ≤ 10μM |
PHKG2_HUMAN | P15735 | Phosphorylase Kinase Gamma Subunit 2, Human | 2000 | 0.28 | Binding ≤ 10μM |
KPCA_HUMAN | P17252 | Protein Kinase C Alpha, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCB_HUMAN | P05771 | Protein Kinase C Beta, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCD_HUMAN | Q05655 | Protein Kinase C Delta, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCE_HUMAN | Q02156 | Protein Kinase C Epsilon, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCL_HUMAN | P24723 | Protein Kinase C Eta, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCG_HUMAN | P05129 | Protein Kinase C Gamma, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCI_HUMAN | P41743 | Protein Kinase C Iota, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCD1_HUMAN | Q15139 | Protein Kinase C Mu, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCD3_HUMAN | O94806 | Protein Kinase C Nu, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCT_HUMAN | Q04759 | Protein Kinase C Theta, Human | 10000 | 0.25 | Binding ≤ 10μM |
KPCZ_HUMAN | Q05513 | Protein Kinase C Zeta, Human | 10000 | 0.25 | Binding ≤ 10μM |
PKN1_HUMAN | Q16512 | Protein Kinase N1, Human | 3500 | 0.27 | Binding ≤ 10μM |
MERTK_HUMAN | Q12866 | Proto-oncogene Tyrosine-protein Kinase MER, Human | 6800 | 0.26 | Binding ≤ 10μM |
KS6A1_HUMAN | Q15418 | Ribosomal Protein S6 Kinase Alpha 1, Human | 2300 | 0.28 | Binding ≤ 10μM |
KS6A2_HUMAN | Q15349 | Ribosomal Protein S6 Kinase Alpha 2, Human | 1500 | 0.29 | Binding ≤ 10μM |
KS6A4_HUMAN | O75676 | Ribosomal Protein S6 Kinase Alpha 4, Human | 1300 | 0.29 | Binding ≤ 10μM |
KS6A5_HUMAN | O75582 | Ribosomal Protein S6 Kinase Alpha 5, Human | 2000 | 0.28 | Binding ≤ 10μM |
KS6A6_HUMAN | Q9UK32 | Ribosomal Protein S6 Kinase Alpha 6, Human | 800 | 0.30 | Binding ≤ 10μM |
ST17B_HUMAN | O94768 | Serine/threonine-protein Kinase 17B, Human | 1900 | 0.29 | Binding ≤ 10μM |
STK33_HUMAN | Q9BYT3 | Serine/threonine-protein Kinase 33, Human | 1700 | 0.29 | Binding ≤ 10μM |
KPCD2_HUMAN | Q9BZL6 | Serine/threonine-protein Kinase D2, Human | 1100 | 0.30 | Binding ≤ 10μM |
DCLK1_HUMAN | O15075 | Serine/threonine-protein Kinase DCLK1, Human | 2100 | 0.28 | Binding ≤ 10μM |
DCLK3_HUMAN | Q9C098 | Serine/threonine-protein Kinase DCLK3, Human | 1100 | 0.30 | Binding ≤ 10μM |
GAK_HUMAN | O14976 | Serine/threonine-protein Kinase GAK, Human | 1100 | 0.30 | Binding ≤ 10μM |
MRCKB_HUMAN | Q9Y5S2 | Serine/threonine-protein Kinase MRCK Beta, Human | 3300 | 0.27 | Binding ≤ 10μM |
MRCKA_HUMAN | Q5VT25 | Serine/threonine-protein Kinase MRCK-A, Human | 9500 | 0.25 | Binding ≤ 10μM |
STK3_HUMAN | Q13188 | Serine/threonine-protein Kinase MST2, Human | 9400 | 0.25 | Binding ≤ 10μM |
CDK16_HUMAN | Q00536 | Serine/threonine-protein Kinase PCTAIRE-1, Human | 180 | 0.34 | Binding ≤ 10μM |
CDK17_HUMAN | Q00537 | Serine/threonine-protein Kinase PCTAIRE-2, Human | 480 | 0.32 | Binding ≤ 10μM |
CDK18_HUMAN | Q07002 | Serine/threonine-protein Kinase PCTAIRE-3, Human | 1100 | 0.30 | Binding ≤ 10μM |
CDK14_HUMAN | O94921 | Serine/threonine-protein Kinase PFTAIRE-1, Human | 110 | 0.35 | Binding ≤ 10μM |
PIM1_HUMAN | P11309 | Serine/threonine-protein Kinase PIM1, Human | 520 | 0.31 | Binding ≤ 10μM |
PIM2_HUMAN | Q9P1W9 | Serine/threonine-protein Kinase PIM2, Human | 650 | 0.31 | Binding ≤ 10μM |
PIM3_HUMAN | Q86V86 | Serine/threonine-protein Kinase PIM3, Human | 600 | 0.31 | Binding ≤ 10μM |
PLK4_HUMAN | O00444 | Serine/threonine-protein Kinase PLK4, Human | 3100 | 0.28 | Binding ≤ 10μM |
TNI3K_HUMAN | Q59H18 | Serine/threonine-protein Kinase TNNI3K, Human | 55 | 0.36 | Binding ≤ 10μM |
KIT_HUMAN | P10721 | Stem Cell Growth Factor Receptor, Human | 4600 | 0.27 | Binding ≤ 10μM |
TGFR2_HUMAN | P37173 | TGF-beta Receptor Type II, Human | 5600 | 0.26 | Binding ≤ 10μM |
FLT3_HUMAN | P36888 | Tyrosine-protein Kinase Receptor FLT3, Human | 3200 | 0.27 | Binding ≤ 10μM |
UFO_HUMAN | P30530 | Tyrosine-protein Kinase Receptor UFO, Human | 3500 | 0.27 | Binding ≤ 10μM |
SRMS_HUMAN | Q9H3Y6 | Tyrosine-protein Kinase Srms, Human | 1400 | 0.29 | Binding ≤ 10μM |
Z80852 | Z80852 | A-431 (Epidermoid Carcinoma Cells) | 75 | 0.36 | Functional ≤ 10μM |
Z81034 | Z81034 | A2780 (Ovarian Carcinoma Cells) | 38 | 0.37 | Functional ≤ 10μM |
Z80682 | Z80682 | A549 (Lung Carcinoma Cells) | 96 | 0.35 | Functional ≤ 10μM |
Z100090 | Z100090 | ABAE (Fibroblast Cells) | 45 | 0.37 | Functional ≤ 10μM |
Z80675 | Z80675 | AG1523 (Fibroblast Cells) | 6700 | 0.26 | Functional ≤ 10μM |
Z80054 | Z80054 | Caco-2 (Colon Adenocarcinoma Cells) | 86 | 0.35 | Functional ≤ 10μM |
Z80064 | Z80064 | CCRF-CEM (T-cell Leukemia) | 52 | 0.36 | Functional ≤ 10μM |
Z80928 | Z80928 | HCT-116 (Colon Carcinoma Cells) | 17 | 0.39 | Functional ≤ 10μM |
Z80156 | Z80156 | HL-60 (Promyeloblast Leukemia Cells) | 46 | 0.37 | Functional ≤ 10μM |
Z100091 | Z100091 | HS27 (Fibroblast Cells) | 51 | 0.36 | Functional ≤ 10μM |
Z80186 | Z80186 | K562 (Erythroleukemia Cells) | 130 | 0.34 | Functional ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 16 | 0.39 | Functional ≤ 10μM |
Z81186 | Z81186 | LS174T (Colon Adencocarcinoma Cells) | 65 | 0.36 | Functional ≤ 10μM |
Z100093 | Z100093 | LX-1 (Lung Carcinoma Cells) | 75 | 0.36 | Functional ≤ 10μM |
Z81225 | Z81225 | M109 (Lung Carcinoma Cells) | 80 | 0.35 | Functional ≤ 10μM |
Z80224 | Z80224 | MCF7 (Breast Carcinoma Cells) | 26 | 0.38 | Functional ≤ 10μM |
Z100095 | Z100095 | MIP (Colon Carcinoma Cells) | 120 | 0.35 | Functional ≤ 10μM |
Z100094 | Z100094 | MLF (Lung Fibroblast Cells) | 72 | 0.36 | Functional ≤ 10μM |
Z80354 | Z80354 | OVCAR-3 (Ovarian Adenocarcinoma Cells) | 54 | 0.36 | Functional ≤ 10μM |
Z80390 | Z80390 | PC-3 (Prostate Carcinoma Cells) | 10000 | 0.25 | Functional ≤ 10μM |
Z80475 | Z80475 | SK-BR-3 (Breast Adenocarcinoma) | 77 | 0.36 | Functional ≤ 10μM |
Description | Species |
---|---|
Acetylcholine regulates insulin secretion | |
Activation of ATR in response to replication stress | |
Activation of CaMK IV | |
Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | |
Activation of NF-kappaB in B cells | |
Activation of NIMA Kinases NEK9, NEK6, NEK7 | |
Activation of the AP-1 family of transcription factors | |
Activation of the pre-replicative complex | |
AKT phosphorylates targets in the cytosol | |
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge | |
APC truncation mutants have impaired AXIN binding | |
APC/C:Cdc20 mediated degradation of Cyclin B | |
Apoptotic cleavage of cellular proteins | |
AXIN missense mutants destabilize the destruction complex | |
Beta-catenin phosphorylation cascade | |
Ca2+ pathway | |
Calmodulin induced events | |
CaMK IV-mediated phosphorylation of CREB | |
CDK-mediated phosphorylation and removal of Cdc6 | |
Cell surface interactions at the vascular wall | |
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | |
Condensation of Prometaphase Chromosomes | |
Condensation of Prophase Chromosomes | |
Constitutive PI3K/AKT Signaling in Cancer | |
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | |
Constitutive Signaling by NOTCH1 PEST Domain Mutants | |
CREB phosphorylation | |
CREB phosphorylation through the activation of CaMKII | |
CREB phosphorylation through the activation of CaMKK | |
CREB phosphorylation through the activation of Ras | |
CRMPs in Sema3A signaling | |
Cyclin A/B1 associated events during G2/M transition | |
Cyclin A:Cdk2-associated events at S phase entry | |
Cyclin B2 mediated events | |
Cyclin D associated events in G1 | |
Cyclin E associated events during G1/S transition | |
DAG and IP3 signaling | |
DARPP-32 events | |
Degradation of beta-catenin by the destruction complex | |
Depolymerisation of the Nuclear Lamina | |
disassembly of the destruction complex and recruitment of AXIN to the membrane | |
Disinhibition of SNARE formation | |
DNA Damage/Telomere Stress Induced Senescence | |
Downregulation of TGF-beta receptor signaling | |
Downstream TCR signaling | |
Dual incision reaction in GG-NER | |
Dual incision reaction in TC-NER | |
E2F mediated regulation of DNA replication | |
E2F-enabled inhibition of pre-replication complex formation | |
Effects of PIP2 hydrolysis | |
EGFR downregulation | |
EGFR interacts with phospholipase C-gamma | |
EGFR Transactivation by Gastrin | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
ERK1 activation | |
ERKs are inactivated | |
Factors involved in megakaryocyte development and platelet production | |
FCERI mediated MAPK activation | |
FCERI mediated NF-kB activation | |
Formation of HIV elongation complex in the absence of HIV Tat | |
Formation of HIV-1 elongation complex containing HIV-1 Tat | |
Formation of incision complex in GG-NER | |
Formation of RNA Pol II elongation complex | |
Formation of the Early Elongation Complex | |
Formation of the HIV-1 Early Elongation Complex | |
Formation of transcription-coupled NER (TC-NER) repair complex | |
G alpha (z) signalling events | |
G0 and Early G1 | |
G1/S-Specific Transcription | |
G2 Phase | |
G2/M DNA replication checkpoint | |
GAB1 signalosome | |
Gastrin-CREB signalling pathway via PKC and MAPK | |
Generic Transcription Pathway | |
Glycogen breakdown (glycogenolysis) | |
Golgi Associated Vesicle Biogenesis | |
Golgi Cisternae Pericentriolar Stack Reorganization | |
GPVI-mediated activation cascade | |
GRB2 events in EGFR signaling | |
GRB2 events in ERBB2 signaling | |
HIV elongation arrest and recovery | |
HIV Transcription Initiation | |
HSF1-dependent transactivation | |
HuR stabilizes mRNA | |
Inactivation, recovery and regulation of the phototransduction cascade | |
Inhibition of PKR | |
Interactions of Tat with host cellular proteins | |
Interferon gamma signaling | |
ISG15 antiviral mechanism | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
MASTL Facilitates Mitotic Progression | |
Meiotic recombination | |
misspliced GSK3beta mutants stabilize beta-catenin | |
mRNA Capping | |
NCAM signaling for neurite out-growth | |
Negative regulators of RIG-I/MDA5 signaling | |
Netrin-1 signaling | |
NoRC negatively regulates rRNA expression | |
NOTCH1 Intracellular Domain Regulates Transcription | |
Nuclear Pore Complex (NPC) Disassembly | |
Oncogene Induced Senescence | |
Orc1 removal from chromatin | |
Oxidative Stress Induced Senescence | |
p53-Dependent G1 DNA Damage Response | |
p75NTR recruits signalling complexes | |
Pausing and recovery of HIV elongation | |
Pausing and recovery of Tat-mediated HIV elongation | |
Phosphorylation of Emi1 | |
Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 | |
Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 com | |
Phosphorylation of the APC/C | |
PI3K events in ERBB2 signaling | |
PIP3 activates AKT signaling | |
PLCG1 events in ERBB2 signaling | |
Polo-like kinase mediated events | |
PPARA activates gene expression | |
Pre-NOTCH Transcription and Translation | |
Ras activation uopn Ca2+ infux through NMDA receptor | |
Recruitment of mitotic centrosome proteins and complexes | |
Recruitment of NuMA to mitotic centrosomes | |
Recycling pathway of L1 | |
Regulation of AMPK activity via LKB1 | |
Regulation of APC/C activators between G1/S and early anaphase | |
Regulation of HSF1-mediated heat shock response | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Regulation of Rheb GTPase activity by AMPK | |
Regulation of signaling by NODAL | |
Resolution of Sister Chromatid Cohesion | |
Response to elevated platelet cytosolic Ca2+ | |
RMTs methylate histone arginines | |
RNA Pol II CTD phosphorylation and interaction with CE | |
RNA Polymerase I Chain Elongation | |
RNA Polymerase I Promoter Escape | |
RNA Polymerase I Transcription Initiation | |
RNA Polymerase I Transcription Termination | |
RNA Polymerase II HIV Promoter Escape | |
RNA Polymerase II Pre-transcription Events | |
RNA Polymerase II Promoter Escape | |
RNA Polymerase II Transcription Elongation | |
RNA Polymerase II Transcription Initiation | |
RNA Polymerase II Transcription Initiation And Promoter Clearance | |
RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | |
Role of phospholipids in phagocytosis | |
RSK activation | |
S33 mutants of beta-catenin aren't phosphorylated | |
S37 mutants of beta-catenin aren't phosphorylated | |
S45 mutants of beta-catenin aren't phosphorylated | |
SCF(Skp2)-mediated degradation of p27/p21 | |
Senescence-Associated Secretory Phenotype (SASP) | |
SHC1 events in EGFR signaling | |
SHC1 events in ERBB2 signaling | |
Signal transduction by L1 | |
Signaling by Activin | |
Signaling by BMP | |
Signaling by constitutively active EGFR | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by ERBB4 | |
Signaling by Hippo | |
Signaling by NODAL | |
Signaling by SCF-KIT | |
Signalling to ERK5 | |
SMAD2/3 MH2 Domain Mutants in Cancer | |
SMAD2/3 Phosphorylation Motif Mutants in Cancer | |
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | |
Sphingolipid de novo biosynthesis | |
Syndecan interactions | |
T41 mutants of beta-catenin aren't phosphorylated | |
Tat-mediated elongation of the HIV-1 transcript | |
Tat-mediated HIV elongation arrest and recovery | |
TGF-beta receptor signaling activates SMADs | |
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | |
TGFBR1 KD Mutants in Cancer | |
TGFBR1 LBD Mutants in Cancer | |
TGFBR2 Kinase Domain Mutants in Cancer | |
TGFBR2 MSI Frameshift Mutants in Cancer | |
Tight junction interactions | |
TRAF3-dependent IRF activation pathway | |
TRAF6 mediated IRF7 activation | |
Trafficking of AMPA receptors | |
Trafficking of GluR2-containing AMPA receptors | |
Transcription of the HIV genome | |
Transcriptional activation of mitochondrial biogenesis | |
Transcriptional regulation of white adipocyte differentiation | |
truncations of AMER1 destabilize the destruction complex | |
Ubiquitin-dependent degradation of Cyclin D1 | |
Unblocking of NMDA receptor, glutamate binding and activation | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation | |
WNT5A-dependent internalization of FZD4 | |
XBP1(S) activates chaperone genes |